stockrow
Saturday 7 November 2026
Export PETS’s income statement to Excel — free account
PetMed Express, Inc.
PETS Healthcare Pharmaceutical Retailers
PetMed Express, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $179.0 million, down 21.1% from fiscal 2025.
- Revenue
- −19.9%
- EPS
- +83.0%
- Free cash flow
- +38.6%
Quarter to June 2026, against a year earlier
1.22
0.02
−1.61%
Follow PETS
Alert me
| Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 7 | 5 | 5 | 4 | 4 | 5 | 5 | 4 | 3 |
P/E ratio |
17.07 | 22.40 | 12.50 | 22.48 | 29.42 | 27.98 | 65.38 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
17.63 | 31.86 | 18.93 | 18.10 | 13.06 | 9.02 | 6.32 | 3.00 | 3.06 | 0.40 |
P/S ratio |
1.64 | 3.06 | 1.67 | 2.03 | 2.32 | 1.91 | 1.33 | 0.35 | 0.38 | 0.27 |
Altman Z″-Score (non-manufacturers) |
13.46 | 15.77 | 16.33 | 13.80 | 10.70 | 8.70 | 6.89 | 3.27 | 3.51 | (4.59) |
P/FCF ratio |
11.13 | 22.87 | 10.63 | 15.79 | 18.75 | 31.08 | 14.61 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
26.18 | 375.41 | 36.08 | 33.41 | 38.25 | 59.72 | 33.86 | 13.40 | 12.31 | (10.05) |
Beneish M-Score |
(3.99) | (2.36) | (2.61) | (2.42) | (3.40) | (1.19) | (2.66) | (0.80) | (3.11) | (4.77) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 36 |
P/B ratio |
4.36 | 7.25 | 3.51 | 4.44 | 5.00 | 4.22 | 2.99 | 0.99 | 1.01 | 1.65 |
Price to Tangible BV |
4.41 | 7.30 | 3.54 | 4.47 | 5.03 | 4.25 | 3.16 | 1.78 | 1.91 | 2.63 |
EV/Sales |
1.40 | 2.78 | 1.31 | 1.66 | 1.93 | 1.50 | 0.91 | 0.15 | 0.14 | 0.15 |
EV/EBITDA |
8.98 | 14.02 | 7.70 | 14.23 | 17.81 | 15.15 | 23.46 | 0.00 | 4.71 | 0.00 |
EV/Operating CF |
7.39 | 20.35 | 8.25 | 12.18 | 14.65 | 22.14 | 8.10 | 9.30 | 6.69 | (0.93) |
EV/FCF |
9.53 | 20.74 | 8.37 | 12.95 | 15.59 | 24.45 | 9.99 | (207.00) | (79.94) | (0.80) |
Quick Ratio |
3.30 | 4.43 | 5.53 | 4.42 | 2.70 | 2.01 | 1.84 | 0.81 | 0.91 | 0.45 |
Current Ratio |
4.46 | 5.81 | 6.79 | 5.30 | 3.59 | 2.68 | 2.27 | 1.30 | 1.26 | 0.84 |
Net Debt/EBITDA |
(1.51) | (1.44) | (2.08) | (3.12) | (3.60) | (4.11) | (10.85) | 50.00 | (8.16) | 0.97 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
2.45 | 2.21 | 1.96 | 1.83 | 1.77 | 1.48 | 1.43 | 1.62 | 1.42 | 1.56 |
Operating CF/Net income |
1.98 | 1.00 | 1.20 | 1.50 | 1.68 | 0.99 | 5.41 | (0.58) | (0.75) | 0.50 |
Capex/Depreciation |
(7.75) | (0.33) | (0.28) | (1.02) | (1.00) | (0.64) | (1.48) | (0.64) | (0.62) | (0.13) |
| 26.98% | 35.66% | 30.14% | 19.53% | 17.63% | 14.14% | 4.40% | (7.22%) | (6.90%) | (100.45%) | |
| 23.46% | 30.11% | 26.09% | 16.69% | 13.95% | 10.19% | 2.96% | (4.42%) | (3.94%) | (49.84%) | |
ROIC |
67.64% | 86.22% | 84.50% | 73.76% | 84.57% | 122.73% | 64.32% | (12.31%) | (3.14%) | (487.12%) |
Return on Tangible Assets |
25.45% | 32.18% | 27.97% | 19.87% | 16.88% | 15.70% | 5.19% | (15.50%) | (13.95%) | (320.82%) |
Average Days of Receivables |
2.65 | 3.06 | 3.27 | 4.94 | 3.11 | 2.56 | 2.57 | 4.37 | 3.73 | 3.89 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
16.24% | 15.90% | 16.55% | 16.90% | 16.92% | 18.33% | 27.02% | 31.33% | 27.50% | 40.36% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.04 | 0.25 | 0.27 | 0.13 |
Share Based Compensation of Revenue |
0.78% | 0.94% | 1.09% | 0.99% | 1.09% | 1.67% | 2.67% | 2.51% | (2.90%) | 0.76% |
Graham Net Nets |
0.15 | 0.10 | 0.23 | 0.18 | 0.16 | 0.18 | 0.22 | 0.21 | 0.18 | (0.18) |
Graham Number |
11.07 | 15.35 | 16.55 | 13.67 | 13.76 | 11.27 | 5.51 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
5.86% | 4.46% | 8.00% | 4.45% | 3.40% | 3.57% | 1.53% | (7.92%) | (7.16%) | (120.61%) |
Free Cash Flow Yield |
8.98% | 4.37% | 9.41% | 6.33% | 5.33% | 3.22% | 6.85% | (0.20%) | (0.46%) | (69.20%) |
Revenue per Share |
12.32 | 13.46 | 13.85 | 14.18 | 15.13 | 13.50 | 12.21 | 13.44 | 11.02 | 8.56 |
Operating CF per Share |
2.33 | 1.84 | 2.21 | 1.94 | 2.00 | 0.92 | 1.37 | 0.21 | 0.23 | (1.36) |
Capex per Share |
(0.52) | (0.03) | (0.03) | (0.12) | (0.12) | (0.09) | (0.26) | (0.22) | (0.25) | (0.22) |
Free Cash Flow per Share |
1.81 | 1.80 | 2.18 | 1.82 | 1.88 | 0.83 | 1.11 | (0.01) | (0.02) | (1.58) |
Cash per Share |
2.90 | 3.83 | 4.91 | 5.18 | 5.92 | 5.51 | 5.13 | 2.71 | 2.66 | 1.02 |
Shareholders Equity per Share |
4.61 | 5.69 | 6.58 | 6.49 | 7.04 | 6.12 | 5.42 | 4.74 | 4.13 | 1.38 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.61 | 5.69 | 6.58 | 6.49 | 7.04 | 6.12 | 5.42 | 4.74 | 4.13 | 1.38 |
Free Cash Flow |
36.60 | 36.68 | 44.52 | 36.53 | 37.64 | 16.75 | 22.54 | (0.19) | (0.39) | (33.01) |
Working Capital |
63.43 | 87.13 | 107.81 | 104.68 | 116.25 | 94.75 | 72.92 | 21.49 | 16.10 | (8.47) |
Capital Expenditures |
(10.60) | (0.70) | (0.62) | (2.31) | (2.43) | (1.75) | (5.26) | (4.51) | (5.11) | (4.61) |
Net Current Asset Value |
62.34 | 86.13 | 106.68 | 103.71 | 114.97 | 94.75 | 72.92 | 20.50 | 15.31 | (8.69) |
EV/EBIT |
9.30 | 14.59 | 8.07 | 15.27 | 19.23 | 16.86 | 37.21 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.04 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 |
Price to Operating Income |
10.87 | 16.09 | 10.25 | 18.62 | 23.11 | 21.43 | 54.42 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.05 | 0.07 | 0.08 | 0.09 | 0.10 | 0.11 | 0.14 | 0.26 | 0.29 | 1.39 |
Cash ROIC |
24.06% | 18.94% | 18.93% | 15.63% | 14.48% | 7.14% | 10.53% | (0.13%) | (0.28%) | (65.56%) |
Accounts Receivable Turnover |
141.10 | 133.56 | 117.26 | 89.00 | 94.43 | 121.01 | 135.54 | 109.14 | 81.06 | 84.74 |
Accounts Payable Turnover |
16.80 | 11.54 | 11.92 | 11.29 | 7.41 | 5.83 | 6.49 | 6.08 | 5.21 | 5.79 |
Inventory Turnover |
7.42 | 8.08 | 8.42 | 10.34 | 8.38 | 5.84 | 6.65 | 7.96 | 7.05 | 8.64 |
Average Days of Payables |
32.71 | 31.68 | 31.58 | 35.37 | 65.83 | 51.38 | 53.79 | 71.38 | 54.49 | 59.24 |
Days of Inventory on Hand |
43.47 | 48.40 | 41.47 | 32.18 | 57.30 | 60.64 | 40.59 | 55.05 | 37.47 | 38.56 |
Average Receivables |
1.77 | 2.05 | 2.42 | 3.19 | 3.22 | 2.25 | 1.83 | 2.51 | 2.80 | 2.11 |
Average Payables |
10.11 | 15.25 | 15.77 | 17.97 | 29.60 | 33.52 | 26.35 | 31.12 | 30.29 | 22.24 |
Average Inventory |
22.91 | 21.78 | 22.35 | 19.63 | 26.15 | 33.44 | 25.74 | 23.79 | 22.38 | 14.91 |
Average Assets |
101.54 | 123.82 | 144.63 | 154.88 | 171.41 | 183.60 | 173.59 | 168.68 | 159.29 | 114.95 |
Average Common Equity |
88.27 | 104.54 | 125.20 | 132.34 | 135.64 | 132.36 | 116.70 | 103.34 | 90.92 | 57.03 |
Columns are period end dates · fundamentals updated 25 Oct 2026